Icariside E4

CAS : 126253-42-7

Ref. 3D-BFA25342

Informations sur le produit

• Nom: Icariside E4
• Synonymes: trans-Dihydrodehydrodiconiferyl alcohol 4′-O-α-L-rhamnopyranoside, α-L-Mannopyranoside, 4-[(2R,3S)-2,3-dihydro-3-(hydroxymethyl)-5-(3-hydroxypropyl)-7-methoxy-2-benzofuranyl]-2-methoxyphenyl 6-deoxy-, Dihydrodehydrodiconiferyl alcohol 9′-O-α-L-rhamnoside, 4-[(2R,3S)-2,3-Dihydro-3-(hydroxymethyl)-5-(3-hydroxypropyl)-7-methoxy-2-benzofuranyl]-2-methoxyphenyl 6-deoxy-α-L-mannopyranoside

Description

Icariside E4 is an indirubin analog that has been shown to have potent anticancer properties. It acts as an inhibitor of protein kinases, which are enzymes that play a crucial role in cancer cell growth and survival. Icariside E4 induces apoptosis, or programmed cell death, in tumor cells by targeting specific signaling pathways involved in cancer development. This compound has been isolated from Chinese herbal medicine and has shown activity against a variety of human cancers, including breast, lung, and prostate cancer. Additionally, Icariside E4 has been detected in urine samples from healthy individuals, indicating its potential use as a biomarker for cancer diagnosis and treatment monitoring. Overall, Icariside E4 represents a promising new class of anticancer agents with significant therapeutic potential.

• Marque: Biosynth

Propriétés chimiques

• Masse moléculaire: 506.5 g/mol
• Formule: C₂₆H₃₄O₁₀
• Degré de pureté: Min. 95%